The Journal of Pharmaceutical Technology (JPharmTech) is an international, peer-reviewed, open-access journal that publishes original research and review articles on the design, development, evaluation and performance of drug products. The journal aims to provide pharmaceutical scientists in academia, industry and regulatory bodies with rigorous, reproducible and practically relevant research that advances drug development from the laboratory to the patient.
JPharmTech welcomes submissions in, but not limited to, the following areas:
- Preformulation and physicochemical characterization of drug substances
- Formulation development of conventional and novel dosage forms
- Drug delivery systems and nanocarriers (lipid-based, polymeric and hybrid systems)
- Biopharmaceutics, drug absorption and permeability (in vitro, in situ and in vivo models)
- Dissolution testing, in vitro–in vivo correlation and bioequivalence
- Pharmacokinetics and pharmacokinetic modelling
- Pharmaceutical analysis, stability and quality control
- Quality by Design, process development and pharmaceutical manufacturing
- Computational, statistical and artificial intelligence approaches in pharmaceutics
- Regulatory science related to drug product development
All manuscripts undergo double-blind peer review. Articles are published in English under a continuous publication model and are made freely available under the Creative Commons Attribution 4.0 International License (CC BY 4.0). JPharmTech charges no submission or publication fees.
JPharmTech publishes original research articles and reviews covering the design, formulation, characterization, manufacturing, quality and performance of medicinal products, as well as studies on products already on the market. The journal follows a continuous publication model: each article is published online with its final citation details as soon as it is accepted and finalized, without waiting for the completion of an issue. Articles published within a calendar year form a single annual volume.
Formulation and drug delivery
- Preformulation, solid-state characterization and drug–excipient compatibility
- Conventional dosage forms (oral, parenteral, topical, ophthalmic, nasal, pulmonary, rectal and vaginal)
- Novel and targeted drug delivery systems
- Pharmaceutical nanotechnology and nanomedicine
- Formulation of biologics, peptides, proteins and nucleic acid-based therapeutics
- Paediatric, geriatric and veterinary dosage forms
- Extemporaneous and magistral preparations
Biopharmaceutics and pharmacokinetics
- Biopharmaceutics, drug solubility, permeability and absorption (in vitro, ex vivo, in situ and in vivo models)
- Dissolution testing and in vitro–in vivo correlation (IVIVC)
- Pharmacokinetics, pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic (PBPK) modelling
- Bioavailability and bioequivalence
Quality, analysis and manufacturing
- Pharmaceutical analysis and quality control of dosage forms
- Stability studies and degradation kinetics
- Quality by Design, process analytical technology and pharmaceutical manufacturing (including continuous manufacturing and 3D printing)
- Pharmaceutical packaging and drug–container interactions
Related product areas
- Pharmaceutical biotechnology
- Radiopharmaceuticals
- Cosmetics and cosmeceutical products
- Nutraceuticals, food supplements and herbal medicinal products
- Drug–device combination products
Emerging and cross-disciplinary fields
- Computational, statistical and artificial intelligence approaches in pharmaceutical sciences
- Regulatory science and the evaluation of marketed products